Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors. [electronic resource]
- ACS infectious diseases 05 2020
- 1121-1139 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't